Juvenile Rheumatoid Arthritis Research Registry
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00090571|
Recruitment Status : Unknown
Verified June 2009 by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Recruitment status was: Recruiting
First Posted : August 30, 2004
Last Update Posted : June 9, 2009
|Condition or disease|
|Juvenile Rheumatoid Arthritis|
JRA is the most common chronic inflammatory pediatric rheumatic disease. JRA may be related to a complex genetic trait. It is rare to have two or more affected siblings, or sibpairs, within one family. The JRA ASP (Affected Sibpair) Registry is a nationwide effort and will collect information and blood samples from JRA sibpairs and their families. Unaffected family members (e.g., mother, father, and unaffected children) are also invited to participate.
Patients and their families may enroll in the registry in one of two ways: patients may contact the registry directly, or they may be referred to the registry through their physician. Once the family has qualified to join the registry, the family will be asked to complete a questionnaire on the medical history of their JRA-affected members. Physicians of the JRA-affected members will be asked to complete questionnaires about their patients' conditions. Family members will also be invited to provide a one-time blood sample. Information collected through the registry will help researchers identify genes involved in JRA susceptibility.
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Research Registry for Juvenile Arthritis|
|Study Start Date :||October 1994|
|Estimated Primary Completion Date :||September 2009|
Two or more biological siblings affected with JIA.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00090571
|Contact: Sandy Kramer, CRCemail@example.com|
|United States, Ohio|
|Cincinnati Children's Hospital Medical Center||Recruiting|
|Cincinnati, Ohio, United States, 45229-3039|
|Principal Investigator: David N. Glass, MD|
|Principal Investigator:||David N. Glass, MD||Children's Hospital Medical Center, Cincinnati|